Insights from Industry Innovators
Carey Powers caught up with five innovative companies at this years OIS XIV in San Diego, to discuss the latest advancements in ophthalmology on the OIS podcast.
Topics included touchless laser therapy for presbyopia, extending the duration of intravitreal treatments, next-generation tear fluid testing, and new imaging methodologies for vitreoretinal conditions. Guests include:
đŸ”¹Alex Lopez, Chief Commercial Officer – Ace Vision Group
đŸ”¹Houman Hamadi, MD, PhD, Co-Founder & Chief Medical Officer – Optigo Biotherapeutics
đŸ”¹Leanne Lavriola, DO, MBA, President & CEO – InnSight Technology
đŸ”¹Nir Katchinskiy, PhD, CEO & Co-Founder – PulseMedica
Resources:
Ace Vision Group: https://acevisiongroup.com/
Optigo Biotherapeutics: https://www.optigobio.com/
InnSight Technology: https://www.innsightech.com/
PulseMedica: https://www.pulsemedica.com/
Explore More Articles
The Modern Presbyopia Exam
It’s time to move towards a more quantitative approach that can better guide treatments for presbyopia By James A. Katz, MD Presbyopia is a manifestation of the aging of the eye that is associated with near and intermediate blurry vision, headache, and eye strain or fatigue. In presbyopia, all of the tissues of the eye …
read moreLaser scleral microporation aids near vision without compromising distance vision
LAS VEGAS — In this Healio Video Perspective from the ASCRS meeting, Robert Ang, MD, discusses results of laser scleral microporation in patients with presbyopia.
read moreLaser scleral microporation treatment may be ‘game changer’ for presbyopia
CARLSBAD, Calif. — In this Healio Video Perspective from the Women in Ophthalmology Summer Symposium, Dagny Zhu, MD, and AnnMarie Hipsley, DPT, PhD, discuss laser scleral microporation for presbyopia. Hipsley said it is important to understand that presbyopia is an aging disease rather than a refractive disorder. Catching it early and treating it can be beneficial for patients. Zhu said laser …
read more